Irish Life Investment Managers’s iShares Biotechnology ETF IBB Stock Holding History

Irish Life Investment Managers’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$19.3M	Buy	+333,579	New	+$19.3M	0.24%	104

Other funds holding IBB

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Irish Life Investment Managers's IBB Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in iShares Biotechnology ETF (IBB) in Q2 2013: 333,579 shares worth $19.3M. The stake represents 0.24% of the portfolio and ranks #104 among its holdings.

232 funds tracked by Wall St. Rank hold IBB as of Q2 2013.

Irish Life Investment Managers held 333,579 shares of iShares Biotechnology ETF worth $19.3M as of Q2 2013.
iShares Biotechnology ETF was a new Irish Life Investment Managers position in Q2 2013.
iShares Biotechnology ETF made up 0.24% of Irish Life Investment Managers's portfolio in Q2 2013, its #104 holding.
232 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.